Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
TPST Stock — Tempest Therapeutics Inc
Tempest Therapeutics Inc (TPST)
Updated October 16, 2026.
TPST is a Stock. Total return is -100.0% over the past 13.9 years, 701.8 points behind SPY at 601.8%.
Tempest Therapeutics is a clinical-stage biotechnology company developing small molecule drugs to treat cancer, with lead candidates including Amezalpat for hepatocellular carcinoma and TPST-1495 for various cancers; it collaborates with Roche on Amezalpat development. The company does not currently distribute to shareholders. Tempest Therapeutics appeals to investors seeking exposure to early-stage cancer drug development with a longer time horizon and higher risk tolerance, as it has not yet generated product revenue.
TPST dividend yield and income
Price as of 2026-10-16.
The payment date is 12/10/2018.
TPST performance versus SPY
Price and return data through 2026-10-16.
Total return is -100.0% over the past 13.9 years, 701.8 points behind SPY at 601.8%. Over the past year its total return — price change plus distributions reinvested — is -94.4%. Its deepest 1-year drawdown was 94.4%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -48.4% | — |
| 3M | -36.0% | — |
| 6M | -72.1% | — |
| YTD | -78.2% | — |
| 1Y | -94.4% | — |
| 2Y CAGR | — | -79.20% |
| 3Y CAGR | — | -80.70% |
| 5Y CAGR | — | -68.10% |
| 10Y CAGR | — | -64.30% |
| Since inception (13.9 years) | -100.0% | -52.80% |
TPST key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 11/12/2012
- Distribution frequency
- None
- Last close
- $0.62 (as of 2026-10-16)
- Market cap
- $10,542,593
- Average volume
- 67109.0
- Payment date
- 12/10/2018
- Beta
- -1.708
- Payout ratio
- 0.0%
- EPS
- $-3.66
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
TPST risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 94.4%.
Who may consider TPST — and who may not
It is a weaker fit for investors who need monthly cash flow (TPST does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on TPST
Frequently asked questions
Does TPST pay monthly?
No. TPST does not currently distribute.
When does TPST pay a dividend?
TPST does not currently distribute. The payment date is 12/10/2018.
How has TPST performed?
Total return is -100.0% over the past 13.9 years, 701.8 points behind SPY at 601.8%. Over the past year its total return — price change plus distributions reinvested — is -94.4%. Its deepest 1-year drawdown was 94.4%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.